1. Home
  2. PGC vs MNMD Comparison

PGC vs MNMD Comparison

Compare PGC & MNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGC
  • MNMD
  • Stock Information
  • Founded
  • PGC 1921
  • MNMD 2019
  • Country
  • PGC United States
  • MNMD United States
  • Employees
  • PGC N/A
  • MNMD N/A
  • Industry
  • PGC Commercial Banks
  • MNMD Pharmaceuticals and Biotechnology
  • Sector
  • PGC Finance
  • MNMD Health Care
  • Exchange
  • PGC Nasdaq
  • MNMD Nasdaq
  • Market Cap
  • PGC 536.5M
  • MNMD 509.2M
  • IPO Year
  • PGC N/A
  • MNMD N/A
  • Fundamental
  • Price
  • PGC $26.54
  • MNMD $9.61
  • Analyst Decision
  • PGC Strong Buy
  • MNMD Strong Buy
  • Analyst Count
  • PGC 2
  • MNMD 7
  • Target Price
  • PGC $37.00
  • MNMD $24.71
  • AVG Volume (30 Days)
  • PGC 130.9K
  • MNMD 1.3M
  • Earning Date
  • PGC 07-21-2025
  • MNMD 07-31-2025
  • Dividend Yield
  • PGC 0.75%
  • MNMD N/A
  • EPS Growth
  • PGC N/A
  • MNMD N/A
  • EPS
  • PGC 1.81
  • MNMD N/A
  • Revenue
  • PGC $238,300,000.00
  • MNMD N/A
  • Revenue This Year
  • PGC $28.96
  • MNMD N/A
  • Revenue Next Year
  • PGC $17.65
  • MNMD N/A
  • P/E Ratio
  • PGC $14.66
  • MNMD N/A
  • Revenue Growth
  • PGC 16.62
  • MNMD N/A
  • 52 Week Low
  • PGC $23.96
  • MNMD $4.70
  • 52 Week High
  • PGC $37.88
  • MNMD $10.49
  • Technical
  • Relative Strength Index (RSI)
  • PGC 48.71
  • MNMD 56.17
  • Support Level
  • PGC $26.19
  • MNMD $7.96
  • Resistance Level
  • PGC $27.23
  • MNMD $10.49
  • Average True Range (ATR)
  • PGC 0.74
  • MNMD 0.55
  • MACD
  • PGC 0.23
  • MNMD -0.06
  • Stochastic Oscillator
  • PGC 75.44
  • MNMD 65.22

About PGC Peapack-Gladstone Financial Corporation

Peapack Gladstone Financial Corp provides banking services. It operates through two segments namely Banking, which involves the delivery of loans and deposits, and Wealth Management Division which includes asset management services. The banking segment includes commercial real estate, multifamily, residential and consumer lending, deposit generation, and Internet banking services. Wealth Management includes investment management services for individuals and institutions; personal trust services, administrator, custodian and guardians, and other financial planning and advisory services. The services provided by the company include checking and savings accounts, money market and interest-bearing checking accounts, certificates of deposit, individual retirement accounts, and other services.

About MNMD Mind Medicine (MindMed) Inc.

Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).

Share on Social Networks: